drugset / Trial / NCT05312385

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)

NCT05312385 ↗

Phase 3 Completed 277 enrolled Sedana Medical
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.

Timeline

Start
2022-04-28
Primary completion
2024-04-26
Completion
2024-10-24

Outcome

Met primary endpoint

release “INSPiRE-ICU 1 has met its primary endpoint” sedanamedical.com ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified — Inhaled
Comparator Propofol Small molecule — Intravenous

Indications

No indication recorded.